Table 4 Breakdown of types of anti-malarials received from each of the sources of treatment (number of cases and percentages)
| Â | 2004 | 2006 | 2008 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Â | Health facilities | Drug shops | General shops | Health facilities | Drug shops | General shops | Health facilities | Drug shops | General shops |
Chloroquine* | Â | 1 (2.1%) | Â | Â | Â | Â | Â | Â | Â |
Artemether-Lumefantrine | Â | Â | Â | Â | Â | Â | 40 (62.5%) | 7 (13.0%) | 1 (16.7%) |
SP | 40 (58.5%) | 20 (42.6%) | 10 (90.9%) | 41 (51.2%) | 33 (70.2%) | 10 (83.3%) | 11 (17.2%) | 35 (64.8%) | 3 (42.9%) |
Amodiaquine | 10 (14.7%) | 9 (19.2%) | Â | 16 (20.0%) | 9 (19.2%) | 1 (8.3%) | 4 (6.3%) | 4 (7.4%) | Â |
Quinine | 38 (55.9%) | 26 (55.3%) | 3 (27.3%) | 24 (42.5%) | 13 (27.7%) | 3 (25%) | 12 (18.8%) | 11 (20.4%) | 2 (28.5%) |
Total | 68 | 48 | 11 | 80 | 47 | 12 | 64 | 54 | 6 |